Search Results

Displaying Results 5676-5700 of 6958 "'J'"

Sep 08, 2025, 08:30 ET UNRIVALED CLOSES OVERSUBSCRIBED SERIES B INVESTMENT ROUND HEADLINED BY BESSEMER VENTURE PARTNERS, INCREASING LEAGUE VALUATION TO $340 MILLION

Trae Young, NBA All-Star with the Atlanta HawksDarryll J. Pines, University of Maryland President, and Sylvia Pines

More news about: Unrivaled


Sep 08, 2025, 08:15 ET QuickLogic Announces Participation in 17th Annual CEO Investor Summit 2025 During SEMICON West

CEO Summit Investor Events, or contact either of the event co-chairs: Laura J. Guerrant-OiyePhone: (808) 960-2642Email: [email protected] 

More news about: QuickLogic Corporation


Sep 08, 2025, 08:00 ET Perfect Bar® Introduces New Chocolate Covered Salted Caramel Mini Protein Bar Just in Time for Back-to-School Snacking

Designed for snackers of all ages, the new Chocolate Covered Salted Caramel Mini joins Perfect Snacks' growing Mini portfolio, alongside Peanut Butter, PB&J, Dark Chocolate Chip Peanut Butter, Double Chocolate, and Chocolate Covered Peanut Butter. With crave-worthy flavors and wholesome ingredients, the

More news about: Perfect Snacks


Sep 08, 2025, 07:00 ET Novo tratamento para doença rara é aprovado no Brasil

baseada em evidências científicas robustas. Referências Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539-551. doi:10.1056/NEJMra1104650.ANVISA. Novos medicamentos e indicações. Disponível em: 

More news about: Amgen


Sep 08, 2025, 07:00 ET Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions

mCRC, including the design of a confirmatory study, leveraging the data in the KRAS mutant patient setting. References: 1.      Bennouna J. Lancet Oncol (14):29-37, 2013 About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep,

More news about: Oncolytics Biotech® Inc.


Sep 08, 2025, 07:00 ET CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

events, or otherwise, other than as required under the Federal securities laws. U.S. Company Contact: Peter J. Mariani, Chief Financial Officer305 College Road EastPrinceton, NJ 08540

More news about: Cytosorbents Corp


Sep 08, 2025, 06:45 ET Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, significantly improved progression-free survival in patients with treatment-naïve CLL/SLL

therapies in mantle cell lymphoma. J Hematol Oncol. 2020;13(1):79. Published 2020 Jun 17. doi:10.1186/s13045-020-00914-1Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies. J Hematol Oncol. 2021;14(1):40. Published

More news about: Eli Lilly and Company


Sep 08, 2025, 03:01 ET Pelagos Data Centres stellt ehrgeizigen Plan für neue 250-MW-Anlage in der Nähe des Hafens von Gibraltar vor

Auftaktveranstaltung des Projekts nahmen neben Picardo, Sokolov und Sir Joe Bossano auch Christian J. A. Ryan, President des Pelagos Data Centres-Projekts für Gibraltar, sowie James Levy KC und Tony Provasoli, Senior

More news about: Pelagos Data Centres


Sep 08, 2025, 00:01 ET Eisai Presents Clinical Study Results of Novel Orexin Receptor Agonist E2086 for Narcolepsy at World Sleep 2025

References1.       Maski. K, et.al. Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy. J. Clinical Sleep Medicine. 2017, 13 (3) p419-,

More news about: Eisai Inc.


Sep 07, 2025, 20:30 ET Innovent Announces Phase 2 Results of Tigulixostat (IBI128, XOI) in Gout Patients were Published at the 27th Asia-Pacific League of Associations for Rheumatology Congress

[6] White WB, Saag KG, Becker MA, et al. (2018). Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med 378:1200-1210. [7]  Prescribing

More news about: Innovent Biologics


Sep 07, 2025, 03:22 ET Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer

Amivantamab-Lazertinib in EGFR-mutant Advanced NSCLC. N Engl J Med. 2025.2 Oxnard GR, Lo PC, Nishino M, et al. Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions. J Thorac Oncol. 2013;8(2):179-184. doi:10.1097/JTO.0b013e3182779d183

More news about: Johnson & Johnson


Sep 06, 2025, 10:55 ET SuperX AI (SUPX) Stock Plunges Amid Allegations of AI Washing -- Hagens Berman

Technology Limited (NASDAQ: SUPX) plunged more than 24% in intraday trading on September 5, 2025, after short-seller J Capital Research released a scathing report alleging the company is "pretending it's in AI."

More news about: Hagens Berman Sobol Shapiro LLP


Sep 06, 2025, 10:00 ET Día Internacional de la Medicina Estética destaca un mercado en plena expansión

McCarthy A, Khalifian S, et al. The Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative Aesthetic Treatment: A Narrative Review. Aesthet Surg J. 2023 Sep 14;43(10):1063-1090. doi: 10.1093/asj/sjad173.  COLEMAN, Kyle M. et al. Neocollagenesis after injection of calcium hydroxylapatite

More news about: Merz Aesthetics Latam


Sep 06, 2025, 07:00 ET Dia Internacional da Medicina Estética destaca mercado em plena expansão

McCarthy A, Khalifian S, et al. The Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative Aesthetic Treatment: A Narrative Review. Aesthet Surg J. 2023 Sep 14;43(10):1063-1090. doi: 10.1093/asj/sjad173. 4. COLEMAN, Kyle M. et al. Neocollagenesis after injection of calcium hydroxylapatite

More news about: Merz Aesthetics Latam


Sep 06, 2025, 03:00 ET RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

Conference on Lung Cancer; September 6-9, 2025; Barcelona, Spain.2 Yang J, et al. Amivantamab Plus Lazertinib vs Osimertinib in First-line (1L) EGFR-mutant (EGFRm) Advanced NSCLC: Final Overall Survival (OS) from the Phase 3

More news about: Johnson & Johnson


Sep 05, 2025, 16:45 ET SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE ACTION, SETTLEMENT HEARING, AND RIGHT TO APPEAR

STEVEN H. COLLIS, RICHARD W. GOCHNAUER, LON R. GREENBERG, JANE E. HENNEY, M.D., KATHLEEN W. HYLE, MICHAEL J. LONG, HENRY W. MCGEE, ORNELLA BARRA, D. MARK DURCAN, and CHRIS ZIMMERMAN, Defendants,

More news about: Cencora


Sep 05, 2025, 16:15 ET Arthur J. Gallagher & Co. to Host Regularly Scheduled Quarterly Investor Meeting with Management

MEADOWS, Ill., Sept. 5, 2025 /PRNewswire/ -- Arthur J. Gallagher & Co. (NYSE: AJG) will be hosting its regularly scheduled quarterly management meeting on Thursday, September

More news about: Arthur J. Gallagher & Co.


Sep 05, 2025, 15:31 ET Classic Automation Launches Dedicated Test Development Center to Drive Parts Availability and Reliability to Extend Automation System Life Cycles

Supported Systems Now Fully Testable Include: Stöber FDS/SDS 4000 & 5000 Series DrivesMitsubishi MELSERVO J2, J3 and J4 Servo DrivesOmron R7D-BP and R88D DrivesHoneywell HC900 Hybrid ControllersABB Symphony Plus IET800 ModulesEmerson

More news about: Classic Automation


Sep 05, 2025, 11:43 ET JUSTIN BOOTS INTRODUCES THE MEN'S HOMELAND COLLECTION

Homeland Collection carries the performance-driven features Justin Boots is known for: All-Day Comfort – Outfitted with the J-Flex® Comfort System and removable Ortholite® insoles, the Homeland Collection keeps feet cushioned and supported through long hours.Jobsite

More news about: Justin Boots


Sep 05, 2025, 07:00 ET On National Cellulite Day, 80% of Women Say Creams and Gadgets Don't Work¹

https://datahorizzonresearch.com/anti-cellulite-care-products-market-3149 5 Stevens WG, et al. Aesthet Surg J. 2022;42(8):937-945. 6 Stevens WG, et al. Aesthet Surg J. 2023;43(4):455-466. 7 RealSelf.com rating downloaded 8.27.24.

More news about: Tiger Aesthetics


Sep 05, 2025, 07:00 ET CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

events, or otherwise, other than as required under the Federal securities laws. U.S. Company Contact: Peter J. Mariani, Chief Financial Officer305 College Road EastPrinceton, NJ 08540

More news about: Cytosorbents Corp


Sep 05, 2025, 06:28 ET 中國移動香港聯同中國移動研究院與中國移動(香港)創新研究院 成功展示全球首個6G開放眾創試驗裝置跨境節點貫通

技術發展的重要里程碑,更是香港深度融入國家數字發展戰略的重要見證。展望未來,憑藉中國移動集團的強大網絡優勢,CMHK 將持續推動 6G 研發與應用,並攜手各界夥伴共創數字時代新價值,惠澤社會大眾。 圖片下載:http://bit.ly/3K4J9vw 關於中國移動香港有限公司  中國移動香港有限公司(簡稱「中國移動香港」)隸屬中國移動有限公司(簡稱「中國移動」),《財富》雜誌「全球500強」企業,香港聯交所股份代號:941;於1997年1月正式提供服務,成為全港首個PCS流動網絡商。

More news about: 中國移動香港


Sep 05, 2025, 04:28 ET PSYCHIC FEVER von LDH JAPAN stürmt SUMMER SONIC, eines der legendärsten Musikfestivals der Welt

sechs Städte und ernteten viel Beifall im Geburtsland der Unterhaltung. Bemerkenswert ist, dass Forbes U.S. die Gruppe lobte und schrieb: „Die J-Pop-Gruppe PSYCHIC FEVER sieht nicht wie eine typische Pop-Boyband aus." Der Artikel hob ihre Individualität sowie Vielseitigkeit hervor, bezeichnete

More news about: LDH JAPAN Inc.


Sep 05, 2025, 04:24 ET PSYCHIC FEVER de LDH JAPAN marque de son empreinte SUMMER SONIC, l'un des festivals de musique les plus légendaires au monde

suscitant une réelle admiration dans le berceau du divertissement. Forbes U.S. a notamment fait l'éloge du groupe, en écrivant : « Le groupe de J-pop PSYCHIC FEVER ne ressemble pas à un boys band pop typique. » Soulignant son individualité et sa diversité, l'article a positionné le groupe comme

More news about: LDH JAPAN Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.